文献速递抗菌药物管理

药师主导选择性审核反馈对门诊尿路及皮肤软组织感染抗生素处方的影响

Impact of pharmacist-led selective audit and feedback on outpatient antibiotic prescribing for UTIs and SSTIs.
PubMed 文献 · Am J Health Syst Pharm · 2021-01-01

该回顾性准实验研究在2个初级保健诊所比较药师主导审核反馈实施前后尿路感染和皮肤软组织感染患者的抗生素处方适宜率。结果显示总体适宜率从27.5%提升至50.5%(P<0.0001),药物选择、疗程和适应症适宜性均显著改善,但感染相关复诊、艰难梭菌感染等结局无显著差异。

要点

  • 药师主导审核反馈使门诊尿路感染和皮肤软组织感染抗生素总体适宜率从27.5%升至50.5%。
  • 药物选择、疗程和适应症适宜性均显著改善,不良事件和感染相关复诊无显著差异。
  • 该策略可作为门诊抗菌药物管理扩展至初级保健场景的可行干预。

核心结论

  • 药师主导的审核反馈门诊管理策略可显著改善尿路感染和皮肤软组织感染的抗生素处方适宜性。

研究设计与样本

  • 回顾性准实验研究,在2个初级保健诊所(家庭医学和内科)纳入400例患者,实施前组200例,实施后组200例。

主要发现

  • 总体抗生素处方适宜率从27.5%提升至50.5%(P<0.0001)。
  • 适宜药物选择率从53%升至70%(P<0.001),适宜疗程率从57.5%升至83.5%(P<0.001),适宜治疗指征率从94%升至98%(P=0.041)。
  • 不良事件、治疗失败、艰难梭菌感染、感染相关复诊或30天内住院率组间无显著差异。

关键数值与推荐

  • 总体方案适宜性依据机构门诊经验性治疗指南,定义为适宜的抗生素选择、剂量、疗程和治疗指征。

临床怎么用

  • 在门诊初级保健中可实施药师主导的审核反馈流程,以提升尿路感染和皮肤软组织感染的抗生素处方质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: An estimated 30% of all outpatient antibiotic prescriptions in the United States are unnecessary. The Joint Commission, in 2016, implemented core elements of performance requiring antimicrobial stewardship programs (ASPs) to expand to outpatient practice settings. A study was conducted to determine whether pharmacist-led audit and feedback would improve antibiotic prescribing for urinary tract infections (UTIs) and skin and soft tissue infection (SSTIs) at 2 primary care practices. METHODS: A retrospective, quasi-experimental study was conducted to evaluate antibiotic prescribing for patients treated for a UTI or SSTI at 2 primary care offices (a family medicine office and an internal medicine office). The primary objective was to compare the rate of appropriate antibiotic prescribing to patients treated before implementation of a pharmacist-led audit-and-feedback process for reviewing antibiotics prescribed for UTIs and SSTIs (the pre-ASP group) and patients treated after process implementation (the post-ASP group). Total regimen appropriateness was defined by appropriate antibiotic selection, dose, duration, and therapy indication in accordance with institutional outpatient empiric therapy guidelines. Secondary objectives included comparing rates of infection-related revisits and Clostridioides difficile infection between groups. RESULTS: A total of 400 patients were included in the study (pre-ASP group, n = 200; post-ASP group, n = 200). The rate of total antibiotic prescribing appropriateness improved significantly, from 27.5% to 50.5% (P < 0.0001), after implementation of the audit-and-feedback process. There were also significant improvements in the post-ASP group vs the pre-ASP period in the individual components of regimen appropriateness: appropriate drug (70% vs 53%, P < 0.001), appropriate duration (83.5% vs 57.5%, P < 0.001), and appropriate therapy indication (98% vs 94%, P = 0.041). There were no significant between-group differences in other outcomes such as rates of adverse events, treatment failure, C. difficile infection, and infection-related revisits or hospitalizations within 30 days. CONCLUSION: A pharmacist-led audit-and-feedback outpatient stewardship strategy was demonstrated to achieve significant improvement in outpatient antibiotic prescribing for UTI and SSTI.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Choi PW, Benzer JA, Coon J, et al. Impact of pharmacist-led selective audit and feedback on outpatient antibiotic prescribing for UTIs and SSTIs. Am J Health Syst Pharm. 2021. PMID: 33769435. doi:10.1093/ajhp/zxab110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。